Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Convergence of Biology, Medicine, and Computing: Biomedical Informatics Entrepreneurs Salon (BIES), HMS, 2/7/19, 4:30 – 6:30PM

Real Time Reporter: Aviva Lev-Ari, PhD, RN

The Biomedical Informatics Entrepreneurs Salon (BIES), which the department cohosts with Harvard University’s Office of Technology Development, meets monthly 4:30–6:30 pm in the Waterhouse Room of Gordon Hall at HMS to promote entrepreneurship at the convergence of biology, medicine, and computing. In addition to hearing industry leaders speak, participants will have the chance to look for collaborators, employees, advisors, customers, or investors. Bring your ideas, get some pizza!

BIES is open to everyone. Tickets are free but limited, and registration is required.

Join our mailing list to receive invitations to future events.

Featured speakers

Featured speakers

Kurt Rohloff (Duality Technologies) and Alexander “Sasha” Gusev (Dana Farber Cancer Institute)

Kurt Rohloff is the co-founder and CTO of Duality Technologies, a start-up commercializing encrypted computing technologies. He is also an associate professor of computer science at NJIT in Newark, NJ. He is a recipient of a DARPA Young Faculty Award and has been the PI on several DARPA and IARPA projects. Prior to co-founding Duality he worked for 9 years in the US defense industry as a senior scientist in the Distributed Systems research group at Raytheon BBN Technologies. He maintains close ties to the US defense industry and has been involved with multiple DARPA projects that have transitioned technologies into operational use and programs of record. His areas of technical expertise include distributed information management, secure computing and high assurance software design. He is the co-founder of the PALISADE open-source lattice encryption library. He received his Bachelor’s degree in Electrical Engineering from Georgia Tech and his Master’s and PhD. in Electrical Engineering from the University of Michigan.

Alexander “Sasha” Gusev is a member of the faculty at the Dana-Farber Cancer Institute and Harvard Medical School. His research focuses on developing statistical methods to understand the genetic architecture of complex disease, uncover biological mechanisms, and identify genetic predictors with prognostic value. He has authored multiple key papers focusing on genetic risk prediction, including analyses of hundreds of epigenomic annotations across common diseases to quantify the contribution of non-coding variation, as well as partitioning of prostate cancer heritability and risk prediction across African American and European populations. His recent work includes methods to predict molecular phenotypes (such as gene expression) into GWAS summary-level data, advancing the concept of a transcriptome-wide association study (TWAS). He received his BS in CS from University of Connecticut and his MS and PhD from Columbia University.

SOURCE

http://dbmi.hms.harvard.edu/events/bies